| Literature DB >> 28331566 |
Reza Safdari1, Elham Maserat2, Hamid Asadzadeh Aghdaei3, Amir Hossein Javan Amoli4, Hamid Mohaghegh Shalmani5.
Abstract
AIM: To survey person centered survival rate in population based screening program by an intelligent clinical decision support system.Entities:
Keywords: Colorectal Cancer; Decision support system; Screening; Survival rate
Year: 2017 PMID: 28331566 PMCID: PMC5346826
Source DB: PubMed Journal: Gastroenterol Hepatol Bed Bench ISSN: 2008-2258
Minimum Data Sets related to survival of CRC
|
|
|
|
|---|---|---|
|
| Current age and diagnosis age | "45 > " = 1 / "65-45" = 2 /"65 < " = 3 |
| Sex | Female =1/ Male = 2/ Transsexual = 3 | |
| Education level | Illiterate = 1 / Primary school = 2 / High school = 3 / University = 4 | |
| Marital Status | Married = 1 / Single = 2 / Divorced = 3 / Widowed = 4 | |
| Ethnicity | Fars = 1 / Turk = 2 / Kord = 3 / Lor = 4 / Other =1 | |
| Religion | Muslim =1/ Christian=2/ jewish=3/ Zoroastruan=4/ Other=5 | |
| Location | City=1/Village =2 | |
|
| BMI | 18.5>=1/18.5-24.9=2/25-29.9=3/30<=4 |
| Exposure to chemical weapons and pollutant-material | Yes=1/NO=0/Unknown=3 | |
| Tobacco Use | Yes=1/NO=0/Unknown=3 | |
| Alcohol Use | Yes=1/NO=0/Unknown=3 | |
| Oral narcotic substance Use | Yes=1/NO=0/Unknown=3 | |
| IV Drug User | Yes=1/NO=0/Unknown=3 | |
| NSAIDs Use | Yes=1/NO=0/Unknown=3 | |
|
| Tumor size (grad I,II) | 20mm> =1/20mm<=2; 35mm> =1/35mm<=2 |
| Tumor topology | Cecum =1, Ascending colon=2, Hepatic flexure=3/ Transverse colon=4/Splenic flexure=4/Descending colon=5/Sigmoid colon=6/ sigmoid colon=7/Colon=8/ rectosigmoid=9/ junctionRectum=10 | |
| Tumor Morphology | Adenocarcinoma=1/ Mucinous adenocarcinoma=2/ Signet Ring Cell Carcinoma=3/ Squamous cell carcinoma=4/ Squamous-cell adenocarcinoma=5/ medullary carcinoma=6/ | |
| Histological Differentiation Grade | Grade cannot be assessed (undetermined grade) =1/Well differentiated (low grade) =2/ Moderately differentiated (intermediate grade) =3/ Poorly differentiated (high grade)=4/Undifferentiated (high grade)=5 | |
| Pt grade | 0 = T0/ T1=1/T2=2/ T3=3/ T4=4 | |
| Pn grade | N0=0/N1=1/ N2=2 | |
| Pm grade | M0=0/M1=1 | |
| Pathologic grade | I=1/II=2/III=3/IV=4 | |
| Advancing grade | Primary grade=1/Advanced grade=2 | |
| Treatment | Surgery=1/chemotherapy, Radiotherapy =2/Biopsy=3 | |
| HNPCC | Yes=1/No=0 | |
| FAP | Yes=1/No=0 | |
|
| Diabetes Mellitus | Yes=1/No=0/Unknown=3 |
| Hypertension disorder | Yes=1/No=0/Unknown=3 | |
| IBD | Yes=1/No=0/Unknown=3 | |
| Personal history of CRC | Yes=1/No=0/Unknown=3 | |
| Family history of CRC | Yes=1/No=0/Unknown=3 | |
|
| Abdominal perforation | Yes=1/No=0 |
| FUO | Yes=1/No=0 | |
| Obstructive Symptoms | Yes=1/No=0 | |
| Abdominal Pain | Yes=1/No=0 | |
| Anemia | Yes=1/No=0 | |
| Rectal Bleeding | Yes=1/No=0 | |
| Change in Bowel Habit | Yes=1/No=0 | |
| Weakness | Yes=1/No=0 | |
| Weight Loss | Yes=1/No=0 | |
|
| Survival quality | Normal activity=1/Non normal activity=2/Dead=3 |
| Vital status | Alive=1/Dead=0 | |
| Survival time | By month |
Figure 1Process of the estimated survival rate for covered population in a screening plan
Figure 2An estimated survival rate for HNPCC patients